APA (7th ed.) Citation

Zedde, M., Losa, M., Donniaquio, A., Gandoglia, I., Sette, M. D., Roccatagliata, L., . . . Pascarella, R. (2026). Drug-Induced Amyloid-Related Imaging Abnormalities: A Neurovascular Perspective on Risk Assessment. Pharmaceuticals (14248247), 19(4), 579. https://doi.org/10.3390/ph19040579

Chicago Style (17th ed.) Citation

Zedde, Marialuisa, Mattia Losa, Andrea Donniaquio, Ilaria Gandoglia, Massimo Del Sette, Luca Roccatagliata, Fabrizio Piazza, Matteo Pardini, and Rosario Pascarella. "Drug-Induced Amyloid-Related Imaging Abnormalities: A Neurovascular Perspective on Risk Assessment." Pharmaceuticals (14248247) 19, no. 4 (2026): 579. https://doi.org/10.3390/ph19040579.

MLA (9th ed.) Citation

Zedde, Marialuisa, et al. "Drug-Induced Amyloid-Related Imaging Abnormalities: A Neurovascular Perspective on Risk Assessment." Pharmaceuticals (14248247), vol. 19, no. 4, 2026, p. 579, https://doi.org/10.3390/ph19040579.